Modified mRNA-Mediated CCN5 Gene Transfer Ameliorates Cardiac Dysfunction and Fibrosis without Adverse Structural Remodeling
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25116262 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Min Ho Song und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Sciences, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea. Hauptthemen laut MEDLINE: CCN Intercellular Signaling Proteins, Fibrosis, Genetic Therapy, Myocardial Infarction. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NHLBI NIH HHS, National Research Foundation of Korea.
Abstract (Originalsprache)
Modified mRNAs (modRNAs) are an emerging delivery method for gene therapy. The success of modRNA-based COVID-19 vaccines has demonstrated that modRNA is a safe and effective therapeutic tool. Moreover, modRNA has the potential to treat various human diseases, including cardiac dysfunction. Acute myocardial infarction (MI) is a major cardiac disorder that currently lacks curative treatment options, and MI is commonly accompanied by fibrosis and impaired cardiac function. Our group previously demonstrated that the matricellular protein CCN5 inhibits cardiac fibrosis (CF) and mitigates cardiac dysfunction. However, it remains unclear whether early intervention of CF under stress conditions is beneficial or more detrimental due to potential adverse effects such as left ventricular (LV) rupture. We hypothesized that CCN5 would alleviate the adverse effects of myocardial infarction (MI) through its anti-fibrotic properties under stress conditions. To induce the rapid expression of CCN5, ModRNA-CCN5 was synthesized and administrated directly into the myocardium in a mouse MI model. To evaluate CCN5 activity, we established two independent experimental schemes: (1) preventive intervention and (2) therapeutic intervention. Functional analyses, including echocardiography and magnetic resonance imaging (MRI), along with molecular assays, demonstrated that modRNA-mediated CCN5 gene transfer significantly attenuated cardiac fibrosis and improved cardiac function in both preventive and therapeutic models, without causing left ventricular rupture or any adverse cardiac remodeling. In conclusion, early intervention in CF by ModRNA-CCN5 gene transfer is an efficient and safe therapeutic modality for treating MI-induced heart failure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Life Sciences, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea.
- Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10019, USA.
- Department of Medicinal & Life Science, College of Science and Convergence Technology, Hanyang University-ERICA, Ansan-si 15588, Republic of Korea.
- Mass General Brigham Gene and Cell Therapy Institute, Boston, MA 02139, USA.
ORCID-Profile: Min Ho Song, Dongtak Jeong
Förderung
- NIH HHS
- NHLBI NIH HHS
- National Research Foundation of Korea
- Hanyang University
- Korean government (MSIP)
- NIH/NHLBI
Zitieren
APA
Song, M. H., Yoo, J., Kwon, D. A., Chepurko, E., Cho, S., Fargnoli, A., Hajjar, R. J., Park, W. J., Zangi, L., & Jeong, D. (2024). Modified mRNA-Mediated CCN5 Gene Transfer Ameliorates Cardiac Dysfunction and Fibrosis without Adverse Structural Remodeling. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25116262
Vancouver
Song MH, Yoo J, Kwon DA, Chepurko E, Cho S, Fargnoli A, et al. Modified mRNA-Mediated CCN5 Gene Transfer Ameliorates Cardiac Dysfunction and Fibrosis without Adverse Structural Remodeling. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25116262
BibTeX
@article{Song2024,
author = {Song, Min Ho and Yoo, Jimeen and Kwon, Do-A and Chepurko, Elena and Cho, Sunghye and Fargnoli, Anthony and Hajjar, Roger J and Park, Woo Jin and Zangi, Lior and Jeong, Dongtak},
title = {Modified mRNA-Mediated CCN5 Gene Transfer Ameliorates Cardiac Dysfunction and Fibrosis without Adverse Structural Remodeling},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25116262}
}
EUVIMED